YOU’LL NEVER WALK ALONE · recognizes Mercy Breast Center for excellence in mammography, breast...
40
YOU’LL NEVER WALK ALONE MERCY CANCER CENTER ANNUAL REPORT 2018-2019
Transcript of YOU’LL NEVER WALK ALONE · recognizes Mercy Breast Center for excellence in mammography, breast...
YOU’LLNEVERWALKALONE
MERCY CANCER CENTER ANNUAL REPORT 2018-2019
2
When you walk through a stormHold your head up highAnd don’t be afraid of the darkAt the end of a stormThere’s a golden skyAnd the sweet silver song of a larkWalk on through the windWalk on through the rainThough your dreams be tossed and blownWalk on, walk onWith hope in your heartAnd you’ll never walk aloneYou’ll never walk aloneWalk on, walk onWith hope in your heartAnd you’ll never walk aloneYou’ll never walk alone– Oscar Hammerstein II / Richard Rodgers
3
Table of ContentsA Message from Cancer Center Leadership ............................................ 4
Awards and Accreditations .................................................................... 5
Commitment to Quality ......................................................................... 6
2018 Accountability and Quality Improvement Measures ................... 6
2018 General Cancer Statistics ............................................................ 8
2018 Cumulative Cancer Statistics...................................................... 10
The Journey Begins ............................................................................ 12
Screening and Diagnosis .............................................................. 13
Radiology ..................................................................................... 13
Laboratory/Pathology ................................................................... 14
Treatment .................................................................................... 15
Surgery ........................................................................................ 15
Radiation ..................................................................................... 16
Breast Care Center ....................................................................... 16
Lung Care Center ......................................................................... 16
Colorectal Center ......................................................................... 16
Gynecologic Cancer ...................................................................... 16
Cancer Research .......................................................................... 17
Outpatient Infusion Center ............................................................ 17
Inpatient Oncology Unit ................................................................. 17
Physicians ................................................................................... 18
Support During Treatment .................................................................. 20
Survivorship and Beyond .................................................................... 22
Community Education and Programming ......................................... 23
Cancer Screenings ....................................................................... 23
Giving Back ....................................................................................... 26
Donors and Gifts .......................................................................... 27
Looking Ahead................................................................................... 30
Spotlight on Lung Cancer
Stereotactic Body Radiotherapy in Early Stage Non-Small Cell Lung Cancer: by Sarah Grabowski, M.D. ................... 32
Role of EBUS Bronchoscopy in Lung Cancer Diagnosis and Staging: by M. Salman Khan, D.O., FCCP .................................. 34
2018 Cancer Registry Report .............................................................. 37
Resources for Patients, Families and Physicians ................................... 38
One Call ............................................................................................ 39
4
Above photo, left to right:
Edward J. Walsh, M.D., Radiation Oncologist and Medical Director, Cancer Services
Aida Safar, M.D., Pathologist and Cancer Liaison Physician
Mitchell Haut, M.D., Medical Oncologist and Chairman, Cancer Protocol Subcommittee
Russell L. Ramey, M.D., FACS, General Surgeon and Surgical Director, Cancer Services
Nicole Haines, RN, BSN, OCN (not pictured) Director, Cancer Services
Elissa Page, MBA, R.T. (R)(T) (not pictured) Clinical Manager, Cancer Services
We at Mercy Cancer Center are grateful to have once again spent a year in the service of our community, offering award-winning cancer care close to home.
While this 2018 Annual Cancer Report is a summary of our outcomes and services, it isn’t really our story. It is the story of all of those who work each and every day to provide the care. It is the story of every patient who enters our doors. It is the story that we share, as we reach our common goals of the best outcomes for each individual with cancer, and those that love them.
The cancer journey can be a terrifying and profoundly lonely one. Thanks to the dedicated providers, volunteers and donors at Mercy Cancer Center, it isn’t a journey anyone in our community needs to make alone.
From screening to survivorship, no one has to make a step of this journey without caring providers by their side. At Mercy Cancer Center, we will make sure you Never Walk Alone.
A message fromCANCER CENTER LEADERSHIP
Vision StatementTo offer the very best in cancer care
close to home through innovative
treatment, cutting-edge technology
and a holistic nurturing of patients
and their loved ones through the
cancer journey.
Mission StatementTo reduce the impact of cancer
today by being a leader in providing
comprehensive cancer care and to
assist in eliminating the threat of
cancer tomorrow.
5
Commission on Cancer (CoC) Accreditation with Gold Commendation
Mercy Cancer Center has been accredited as a Comprehensive Community Cancer Program since 1986 and has earned Accreditation with Commendation since 2004. Accreditation by the CoC is given only to those facilities that have voluntarily committed to providing the highest level of quality cancer care and that undergo a rigorous evaluation process every three years. Only one in four hospitals that treat cancer receives accreditation and an even smaller number receive accreditation with commendation.
AWARDS AND ACCREDITATIONS
Outstanding Achievement Award Recognized as one of the best 4 times in a row!
The Outstanding Achievement Award is an honor bestowed by the Commission on Cancer to only the elite of Cancer Centers across the country. The award is designed to recognize cancer programs that strive for excellence in providing quality care to cancer patients and is awarded to facilities that receive a commendation level of compliance for all critical standards including cancer committee leadership, cancer data management, clinical management, research, community outreach and quality improvement. Very few cancer centers have received this award four times consecutively, which is a testament to Mercy Cancer Center’s steadfast commitment to excellence.
Designated as Breast Imaging Center of Excellence by the American College of Radiology
The Breast Imaging Center of Excellence designation is awarded to breast imaging centers that achieve excellence by seeking and earning accreditation in all of the ACR’s voluntary breast-imaging accreditation programs and modules, in addition to the mandatory Mammography Accreditation Program. The designation recognizes Mercy Breast Center for excellence in mammography, breast ultrasound, ultrasound-guided breast biopsy and stereotactic breast biopsy.
As an award-winning organization, Mercy Cancer Center provides services through a fully comprehensive and coordinated approach. Mercy Cancer Center physicians and personnel work tirelessly together to ensure patients receive excellence in cancer care while staying close to home. For this reason, we proudly display the many awards that validate our status as a premier cancer center.
Stereotactic Breast Biopsy Accreditation
This Accreditation provides facilities performing stereotactic breast biopsy procedures with peer review and constructive feedback on their staff’s qualifications, equipment, quality control (QC), quality assurance, accuracy of needle placement, image quality and dose.
CAP 15189SM Accredited by the College of American Pathologists
Mercy Medical Center’s Department of Pathology and Laboratory Medicine was the first hospital in northeast Ohio to achieve CAP 15189SM accreditation based on quality standards outlined by the International Organization for Standardization. Accreditation focuses on improved patient safety and risk reduction for quality and competence particular to medical laboratories.
Certified Professional Caregivers
• Oncology Certified Nurses (OCN)
• Certified Chemotherapy and Biotherapy Providers
• Certified Clinical Research Professionals
• Certified Breast Patient Navigator in Imaging and Cancer (CBPN-IC)
5
6
Mercy Cancer Center doesn’t just want to support you in your cancer journey, we want to provide the best quality care possible, which is critical to good outcomes and optimal cancer survivorship. Performance measures give the healthcare community a way to assess quality of care against recognized standards. One of the ways that Mercy Cancer Center assesses quality is to compare our performance through American College of Surgeons Commission on Cancer (CoC) adopted quality measures and National Quality Forum (NQF) endorsed measures to those of other hospitals
in Ohio and the United States. Mercy meets or exceeds most of these by means of statistical comparison. If we identify an area where we do not, our quality committees review each case and institute changes as needed.
COMMITMENT TO QUALITY
Accountability and Quality Improvement Measures (Latest data available from 2016)
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
100%94% 93%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
100% 97% 94%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
80%90% 90%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
99%92% 91%
MERCY OHIO U.S.
BREAST CANCER PERFORMANCE MEASURES
National Standard for Breast Conserving Surgery and Radiation Therapy (Accountability)
Radiation therapy is administered within one year of diagnosis for women under the age of 70 receiving breast conserving surgery for breast cancer. Mercy exceeded national and state norms.
National Standard for Adjuvant Hormonal Therapy for Hormone Receptor Positive Breast Cancer Patients (Accountability)
Tamoxifen or third generation aromatase inhibitor is considered or administered within one year of diagnosis for women with AJCC T1cN0M0 or Stage I hormone receptor positive breast cancer. Mercy data was completely compliant, exceeding national and state norms.
Radiation Therapy is Recommended or Administered Following Any Mastectomy Within 1 Year (365 days) of Diagnosis of Breast Cancer for Women with 4 or More Positive Regional Lymph Nodes (Accountability)
Though Mercy was slightly below national and state, based on the volume of cases, this was not considered statistically significant.
Image or Palpation-guided Needle Biopsy to the Primary Site is Performed to Establish Diagnosis of Breast Cancer (Quality Improvement)
Mercy data exceeded state and national norms.
7
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
100% 96% 93%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
88% 93% 93%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
NO DATA
93% 89%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
NO DATA
64% 66%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
100% 94% 93%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
100%94% 94%
MERCY OHIO U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
23.25
45.5
67.75
90
Mercy Ohio U.S.
1
25.5
50
74.5
99
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
24
47
70
93
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
18.25
35.5
52.75
70
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
1
25.75
50.5
75.25
100
Mercy Ohio U.S.
100%91% 90%
MERCY OHIO U.S.
Combination Chemotherapy is Recommended or Administered Within 4 Months (120 days) of Diagnosis for Women Under 70 with AJCC T1cN0, or Stage IB-III Hormone Receptor Negative Breast Cancer (Accountability)
Mercy was fully compliant with this standard, exceeding state and national norms.
COLON CANCER PERFORMANCE MEASURES
At Least 12 Regional Lymph Nodes Are Removed and Pathologically Examined for Resected Colon Cancer (Quality Improvement)
Mercy was slightly below state and national norms, however, this was not considered statistically significant.
Adjuvant Chemotherapy is Recommended, or Administered Within 4 Months (120 days) of Diagnosis for Patients Under the Age of 80 With AJCC Stage III (Lymph Node Positive) Colon Cancer (Accountability)
No Mercy data available for comparison.
GASTRIC CANCER PERFORMANCE MEASURES
At Least 15 Regional Lymph Nodes Are Removed and Pathologically Examined for Resected Gastric Cancer (Quality Improvement)
No Mercy data available for comparison.
LUNG CANCER PERFORMANCE MEASURES
Systemic Chemotherapy is Administered Within 4 Months to Day Preoperatively or Day of Surgery to 6 Months Postoperatively, or it is Recommended for Surgically Resected Cases with Pathologic Lymph Node-positive (pN1) and (pN2) NSCLC (Quality Improvement).
Mercy exceeds both state and national norms.
Surgery is Not the First Course of Treatment for cN2, M0 Lung Cases (Quality Improvement)
Mercy exceeded the state and national norms.
RECTAL CANCER PERFORMANCE MEASURES
Preoperative Chemo and Radiation are Administered for Clinical AJCC T3N0, T4N0, or Stage III; or Postoperative Chemo and Radiation are Administered Within 180 Days of Diagnosis for Clinical AJCC T1-2N0 with Pathologic AJCC T3N0, T4N0, or Stage III; or Treatment is Recommended; for Patients Under the Age of 80 Receiving Resection for Rectal Cancer (Quality Improvement)
Mercy exceeded both state and national norms.
8
2018GENERAL CANCER STATISTICS
8
9
Stage 0 Stage I Stage II Stage III Stage IV Unknown Total
Breast 37 72 41 7 6 4 167
Bronchus & Lung 0 38 11 28 54 4 135
Prostate Gland 0 6 66 13 4 2 91
Bladder 23 19 3 1 3 0 49
Colon 13 18 5 7 0 0 43
Source: Mercy Cancer Center Registry, 2018
Mercy Cancer Center 2018
Top 5 Sites By AJCC Stage at Diagnosis
Oral Cavity and Pharynx (28) 18 10
Esophagus (8) 7 1
Stomach (9) 7 2
Small Intestine (2) 0 2
Colon (32) 11 21
Rectum & Rectosigmoid (18) 13 5
Anus & Anal Canal (3) 1 2
Liver and Intrahepatic Bile Duct (7) 4 3
Other Biliary (4) 3 1
Pancreas (15) 9 6
Larynx (11) 8 3
Lung and Bronchus (134) 64 70
Pleura (2) 0 2
Soft Tissue (2) 1 1
Skin (43) 22 21
Breast (167) 0 167
Cervix Uteri (2) 0 2
Corpus and Uterus (13) 0 13
Ovary (5) 0 5
Vulva (2) 0 2
Prostate (91) 91 0
Testis (6) 6 0
Urinary Bladder (49) 37 12
Kidney and Renal Pelvis (13) 4 9
Ureter (4) 3 1
Other Urinary Organs (1) 0 1
Brain (6) 3 3
Cranial Nerves, Other Nervous System (3)
2 1
Thyroid (36) 7 29
Other Endocrine, Including Thymus (4)
3 1
Hodgkin Lymphoma (5) 2 3
Non-Hodgkin Lymphoma (18) 10 8
Myeloma (9) 4 5
Leukemia (8) 2 6
Sarcoma (1) 1 0
Miscellaneous (19) 7 12
Total (780) 350 430
Source: Mercy Cancer Center Registry, 2018
Primary Site (Total # of Cases) M F
Primary Site (Total # of Cases) M F
Primary Site (Total # of Cases) M F
Mercy Cancer Center Primary Site Table
2018 Analytic Cases
10
2018CUMULATIVE CANCER STATISTICS
1.31% 2.03%
6.36%
21.02%
32%
25.69%
10.59%
0.99%1.33%
4.32%
12.24%
21.94%
26.16%
21.77%
10.68%
1.57%
0%
10%
20%
30%
40%
0-29 30-39 40-49 50-59 60-69 70-79 80-89 90+
Female
Male
Source: Mercy Cancer Center Registry, 2018
Source: Mercy Cancer Center Registry, 2018
Stage 0 Stage I Stage II Stage III Stage IV Unknown Total
Breast 770 1286 865 277 124 101 3423
Bronchus & Lung 6 498 174 688 1085 173 2626
Prostate Gland 0 185 1372 140 85 59 1841
Bladder 433 205 84 32 63 20 837
Colon 109 197 264 233 179 58 1040
624
708661 637
670626
701733 742
681735
896
795 816873
983942
988943
836780
232191
276 269222 234
297
95 85 75 95 11480 83 76 68 91 95 91 77 54
0
100
200
300
400
500
600
700
800
900
1000
1100
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ‘98 ’99 ’00 ’01 ’02 ’03 ’04 ’05 ’06 ’07 ’08 ’09 ’10 ’11 ’12 ’13 ’14 ’15 ’16 ’17 ’18
AnalyticNon-Analytic
Source: Mercy Cancer Center Registry, 2018
Mercy Cancer Center 1998-2018 Cases
Analytic vs. Non-Analytic
Mercy Cancer Center 1998-2018
Top 5 Analytic Cases by Stage
Mercy Cancer Center 1998-2018 Cases
Age & Gender Distribution
1111
12
Cancer can stop you in your tracks and put life on hold. Mercy Cancer Center will be there with you through your entire journey. We will guide you along the way with care and compassion so you’ll never walk alone.
THE JOURNEY BEGINS
12
13
SCREENING/DIAGNOSISNo one can take away the fear surrounding a diagnosis of cancer. However, having the latest technology to provide quick answers and high quality treatment along with supportive staff at your side can make a difference. At Mercy Cancer Center, you can be assured that the latest technology for diagnosis and treatment is available to you.
RadiologyState-of-the-art diagnostics, including MRI, CT and PET are available to accurately image cancer. This includes interventional radiology, which provides a wide array of interventions to assist physicians in the diagnosis and treatment of cancer patients.
“I am grateful to my Oncologist and the nurses at
the Mercy Cancer Center. From the front desk staff
on, I was treated with respect and professional
excellence. The diligence and attentiveness of the
nurses made me feel that I was in the best possible
hands for my intravenous chemotherapy infusions.
I felt safe. Thank you!”
– Cheryl | Ovarian Cancer Patient
“Every day, I bear witness to the most intimate
moments in a patient’s life. I get to insert a bit of
comfort and support in their minds at some of
the most tumultuous times. I am inspired by my
patients. They make me want to be a better person.
I do it for them.”
– Amy | Nurse Navigator
Thomas Vesy, M.D. Radiologist
13
Visit our Radiology webpage
14
Laboratory/PathologyOur accredited laboratory and pathology departments have the latest in testing, including specialized cancer testing for unique genetic mutations that open up new options in the treatment of cancer. Many of these tests are available with rapid results to minimize the angst of waiting on a diagnosis.
Visit our Lab/Path webpage
“The nurse navigator helped us fill out
all of our disability paperwork when
my husband got diagnosed with lung
cancer which was an awesome help!
Everyone was very helpful, kind, and
considerate with my son when he had
cancer, and when both me and my
husband were also diagnosed with
our cancers.”
– Verna | Breast Cancer Survivor and Caregiver
“I have been a nurse navigator for almost 20 years. I am asked everyday why I do
this. My answer is simple. I do this because of the patients. I try to care for the
patients whose lives have been affected by breast cancer like I would want my
sisters, mom, daughter or myself taken care of. This is a scary journey and if I can
help in any way make it just a little less scary, then I have been successful. There is
a quote from Albert Einstein that a nurse mentor of mine gave me. “There are two
ways to live your life. One is as though nothing is a miracle. The other is as though
everything is a miracle.” I see this in my patients every single day. They inspire me
to be a better nurse and person and for that I am eternally grateful.”
– Diane | Nurse Navigator
Aida Safar, M.D. Pathologist
14
15
TREATMENTSurgeryOur state of the art radiation therapy department can offer precise treatment of cancerous tumors, shorter treatment courses and improved outcomes. The staff are there for patients throughout treatment, providing consistent support every step of the way.
Visit our Surgery webpage
“Being diagnosed at age 41 of triple positive breast
cancer on March 26, 2019 has opened my eyes to
a world I really knew nothing about! Being a nurse I
now understand what my patients are going through.
I understand their fear, their sadness, their anger. I
understand the side effects of chemo, the endless
doctor appointments, and the pain from surgeries! But
I also understand that there are amazing people out
there, like nurses and doctors, who have dedicated their
lives to save ours and I am truly thankful for that!”
– Shea | Breast Cancer Patient
“I love my job in the cancer center because it gives me
the opportunity to meet some genuine, amazing people
that I otherwise may have never crossed paths with. As a
radiation therapist, I am able to establish a relationship
with my patients, as most of them are coming in every
day for treatment, some for up to 9 weeks. It’s rewarding
knowing I can be a smiling face they trust to deliver their
treatment but at the same time I am here to offer
encouragement or simply lend an ear as my patients go
through one of the toughest journeys of their lives.”
– Amannda | Radiation Therapist
Russell Ramey, M.D. General Surgeon
15
16
Breast Care CenterEquipped with the latest in screening technology, including digital mammography, Mercy’s breast center won’t make you wait to find out if you need a biopsy. A radiologist will give you your diagnostic mammogram results at the time of your test, and a navigator will schedule you for your next step. Dedicated navigators will be available to you throughout the process, to ensure that you get everything needed for optimal outcomes. Bi-weekly multidisciplinary conferences are held to review breast cancer cases and discuss the best course of treatment for each individual case.
Lung Care CenterMercy offers low dose lung screening for high risk individuals to identify lung cancer early. Once a cancer is identified, a multidisciplinary team discusses the best approach for treatment. A dedicated lung navigator ensures the complex care needed is organized and timely.
Colorectal CenterComprised of experienced surgeons, radiologist, pathologists and a dedicated colorectal nurse navigator, the colorectal cancer team at Mercy works to provide screening, diagnosis, customized treatment and survivorship care throughout the cancer experience.
Gynecologic CancerMercy is proud to welcome gynecologic oncology in 2018. Conveniently located within the cancer center, Mercy’s gynecologic oncologists provide the highest standard of care for women’s cancers, including robotic surgery. A dedicated gynecology navigator follows you throughout your cancer journey to help with physical, psychosocial and practical issues that arise.
Visit our Radiation webpage
Edward J. Walsh, M.D. Medical Director, Cancer Services l Radiation Oncologist
RadiationCancer is complicated. It takes a team to support you and get everything you need throughout your cancer journey. At Mercy Cancer Center, you can be assured that whatever your diagnosis, a team will be available to help you.
17
Outpatient Infusion CenterMercy Outpatient Infusion Center is located just steps away from the cancer center entrance with dedicated parking and valet service available. With 14 beds, private cubicles and oncology trained nurses, you can be confident you will receive compassionate, comfortable, quality care.
Inpatient Oncology UnitNo one wants to be in the hospital, but if chemotherapy, symptoms, testing, oncologic emergencies, or end of life care requires hospitalization, you can be sure that the needs of both patient and family will be meet. Our 17-bed Inpatient Oncology Unit is staffed with specially trained nurses who work with an interdisciplinary team of experts to address physical, emotional and spiritual needs.
Mitchell Haut, M.D. Oncology/Hematology Physician
Cancer ResearchYou don’t have to travel to have access to the latest advances in cancer care. Mercy’s robust clinical trials service brings cutting edge treatments to the local community.
18
Breast Care Center
Elizabeth Russ, M.D. Radiologist
Mark DeGalan, M.D., PhD Radiologist
Kristin Kavanagh, M.D. Interventional Radiologist
Tasneem Khimji, M.D. Radiologist
Thomas Vesy, M.D. Director of Women’s Imaging, Radiologist
Physician Specialists
PHYSICIANSMercy Cancer Center is proud to be affiliated with an elite group of physicians who specialize in the treatment of cancer. Our team includes medical oncologists, radiologists, pathologists, surgeons, pulmonologists and others. Physicians are board certified in their specialties and work collaboratively in the care of cancer patients.
Vidhi Adlakha, D.O.Plastic/Reconstructive
Surgeon
Greg Boone, M.D.Medical Director of Breast Center, General Surgeon
Nader Botros, M.D.Pulmonologist
James Cardella, M.D.General Surgeon
Sarah Grabowski, M.D.Radiation Oncologist
Mitchell Haut, M.D.Medical Oncologist
M. Salman Khan, D.O., FCCP
Pulmonologist
Albert Kim, M.D.Pulmonologist
Matthew Krauza, M.D.Pulmonologist
Serrie Lico, M.D.Cardiothoracic Surgeon
Michael McCormack, D.O.Plastic/Reconstructive
Surgeon
Scott McGee, M.D.Medical Oncologist
Nagaprasad Nagajothi, M.D.
Medical Oncologist
Noman Rafique, M.D.Medical Oncologist
Russell Ramey, M.D.General Surgeon
Vishal Sawhney, M.D.Pulmonologist
Kirby Sweitzer, M.D.General Surgeon
Mark Tawil, M.D.Cardiothoracic Surgeon
Sharon Wagamon, M.D.Medical Oncologist
Edward Walsh, M.D.Radiation Oncologist
Gynecologic Oncology
Steven Andrews, M.D. Gynecologic Oncologist
Robin Laskey, M.D. Gynecologic Oncologist
Gynecologic Oncology
Steven Andrews, M.D. Gynecologic Oncologist
Robin Laskey, M.D. Gynecologic Oncologist
John Perry, M.D.Cardiothoracic Surgeon
19
Cancer Nurse Navigators
Cancer Research Radiation Therapy
Certified by National Board for Certification Hospice and
Palliative Nurses
Angeline Barbato, RN, BSN
Colon Nurse Navigator330-588-4686
Amy Crawford, RN
Breast Nurse Navigator330-588-4674
Jaymi Doerfler, RN, BSN, OCN
Gynecology Nurse Navigator330-588-4588
Bobbi Freeman, RN, BSN, OCN
Cancer Nurse Navigator330-458-4214
Katie Wilson, RN, BSN, OCN
Lung Nurse Navigator330-430-2777
Diane Wofsey, RN, BSN, CBPN-IC
Breast Nurse Navigator330-580-4727
Joan Kaufman, RN, OCN330-489-1274
Jane Westfall, RN, BSN, OCN
330-588-4589
Gayle Doney, RN330-489-8118
Janet MuckleyTrials Support: 330-430-2788
Sarah Grabowski, M.D. Radiation Oncologist
Edward J. Walsh, M.D. Radiation Oncologist
Jeffrey Hopcian, M.D. Jamesetta Lewis, D.O.
Brian Aronson, M.D. Interventional Radiologist
Kristin Kavanagh, M.D. Interventional Radiologist
Stephanie Spicer, CNP, ACHPN
Pain Management
Aida Safar, M.D. Pathologist
Khatib Jafri, M.D. Pathologist
Francisco Paras Jr, M.D. Pathologist
Clinical Laboratory & Pathology Interventional Radiology
Palliative Care
Beth A. Canfield, CNP Jaime DeMarco, NP
Tracey Ward, NPNicholas F. Volchko, M.D.
Tomi Haidet, CNP Michael Smith, PADavid P. Gutlove, M.D. Medical Director
Gamaliel Batalla, M.D.
20
Keep moving forward, making progress and accepting help along the way.
SUPPORT DURING TREATMENT
20
21
Throughout the cancer journey, much more than treatment for the disease
is needed. At Mercy Cancer Center, we realize that it takes many different
types of support to cope with the most difficult time in your life. That’s why
we offer a wide range of services to meet every kind of need.
From optimal symptom control via our pain management and palliative care services, to in-person support with our monthly support groups, Mercy Cancer Center continues to explore ways to be there for you, and better address the unique concerns that come with a cancer diagnosis.
We offer physical, occupational, speech, and lymphedema therapies to optimize function and minimize the physical impact of cancer. Complementary therapies work as an adjunct to traditional treatment, offering comfort and relaxation.
Pastoral care provides spiritual support, advance directives, and bereavement support. Mercy Boutique provides wigs, mastectomy bras and breast prostheses, lymphedema sleeves and skin care products in a warm, welcoming atmosphere.
Mercy Cancer Center is committed to quality, compassionate care throughout life. Mercy Hospice provides 24/7 access to care for terminally ill patients and their families, with symptom control, supplies and supportive staff and volunteers to be by your side though life’s most difficult time.
As part of our ongoing efforts to support cancer survivors, Mercy Cancer Center continues to provide survivor care plans to patients completing their treatment, maintains a survivor garden at Price Park in North Canton, and hosted our annual viewing of Lilly Oncology on Canvas, as well as a candle lighting ceremony in honor of cancer survivors during national cancer survivor month in June.
21
22
SURVIVORSHIP AND BEYONDPlanning for your future and helping others move forward.
22
2323
At Mercy Cancer Center, we don’t just treat cancer. We provide services that help patients move on with life, establish
their new normal, and cope with the challenges ahead. We provide detailed survivor care plans that summarize the
diagnostic testing and treatment that was provided, but also serve as a roadmap for ongoing care and surveillance.
Survivor care plans are a tool that help patients and providers stay on track for a healthy future. Navigators continue to
be available to patients, and provide resources for the next step in their journey. Mercy Cancer Center hosts a variety of
events each year to help screen for cancer, prevent cancer, educate and raise awareness, and celebrate survivors and
their friends, families, and caregivers.
COMMUNITY EDUCATION AND PROGRAMMINGMercy Cancer Center works hard to bring awareness about cancer prevention and healthy lifestyles to our community. We care about the health of our community, and our efforts throughout the year are aimed at addressing the health challenges everyone in our community faces.
■
CANCER SCREENINGSMercy Cancer Center provided a free oral cancer screening, with 2 people screened, as well as free skin cancer screenings throughout 2018 and 2019, with a total of 213 people screened, and 58 recommended for further follow up.
■ Participated in six community education talks about breast cancer, with a combined attendance of 440.
■ Held monthly general cancer and breast cancer support groups throughout 2018 and 2019.
■ Continued to sponsor Mercy’s ANGEL (African American Women Nurturing and Giving Each Other Life) Network, with quarterly educational meetings, and serving numerous community events.
■ Held 40 smoking cessation classes throughout 2018 with a combined attendance of 86.
■ Attended 14 community health fairs, providing information on cancer prevention, screening, and diagnosis to combined total of 1410
■ Participated in Relay for Life, Making Strides Against Breast Cancer, Real Men Wear Pink and Komen Race for the Cure, raising funds and awareness in the fight against cancer!
■ Mercy has performed a total of 45 free screening mammograms for uninsured/underinsured women in 2018, and 16 year to date for 2019.
■ Mercy has a robust lung screening program, with 528 Low Dose CT Lung screenings done and 13 cancers identified in 2018, and 463 screenings with 7 cancers identified year to date in 2019.
24
Relay for LifeMercy Cancer Center was again a major sponsor of the Jackson-Canton Relay for Life held on June 2, 2018 and June 8, 2019 in Jackson Township. Each year, Mercy teams raise considerable money for the cause.
Real Men Wear PinkMercy Cancer Center has supported this event from its beginning in 2016 with our male champions who wear pink and fundraise for the cause throughout October. Dr. Greg Boone served as Mercy’s Real Man in 2018 raising a total of $26,000 and Dr. Thomas Vesy is currently serving as our Real Man in 2019. Dr. Vesy is already raising considerable money for breast cancer this year!
Mercy ANGEL NetworkMercy Cancer Center formulated the ANGEL Network (African American Women Nurturing and Giving Each Other Life) to assist in impacting the higher mortality rate of breast cancer among African American women in our community. This dynamic network of volunteers encourage African American women to take charge of their breast health through early detection programs, access to screenings and education about breast health practices. Over 70 women currently serve as ANGELs and work in concert with Cancer Center personnel to increase awareness and educate women of color.
Thomas Vesy, M.D. Director of Women’s Imaging, Radiologist
Greg Boone, M.D.Medical Director of Breast Center, General Surgeon
Relay for Life
Mercy ANGEL Network
25
Komen Race for the CureMercy personnel attended this annual 5K race/walk held on October 5, 2019 at Canal Park Stadium, Downtown Akron. Mercy has been a long-time supporter and also a grant recipient in the past.
Making Strides Against Breast CancerMercy Cancer Center was a sponsor of Making Strides held at Malone College in 2019. Cancer Center staff provide free literature and information along with monetary support for the event.
Lilly Oncology on Canvas Art DisplayMercy Cancer Center again hosted a viewing of Oncology on Canvas to celebrate Cancer Survivor’s Week. The exhibit was presented by Lilly Oncology, in partnership with the National coalition for Cancer Survivorship. The artwork prints are created by cancer survivors and caregivers.
Senior Health FairThe Faith in Action of Western Stark County’s Senior Health, Wellness & Lifestyle Fair provides around 300 western Stark County Seniors with education and information on health and wellness, including cancer prevention, screening, and diagnosis. The 2019 event focused on the “Know Before You Go” campaign, helping people understand what constitutes a visit to their primary care physician, a specialist, an urgent care center, or an emergency department, and how to prepare for each visit.
Lilly Oncology on Canvas
Senior Health Fair
Komen Race for the Cure Making Strides Against Breast Cancer
26
How can you make the journey easier for others?
GIVING BACK
26
27
American Breast Cancer Foundation
Mrs. Christy R. Barker
Ms. Tara L. Barker
Barleys Heating & Air Conditioning Inc.
Mr. and Mrs. Steven D. Barnett
Mr. Dale E. Brahler
Dr. Elizabeth Butterworth and Mr. Mark Butterworth
Mrs. Linda M. Carson
Mr. and Mrs. William Carson
Mr. and Mrs. Harry F. Collmar
Ms. Karen S. Coughlin
Element 26 Fitness LLC
Mr. Leo D. Evans
Father & Son Property Maintenance, LLC
Ms. Beth Finnicum
Mrs. Jane A. Fleenor
Dr. Sarah F. Grabowski
Mr. and Mrs. Perry Griffin
Mr. and Mrs. Bruce A. Gula
Dr. and Mrs. David P. Gutlove
HBOH LLC
Mr. and Mrs. Mark Hickey
J.H. Cancer Fund
Mrs. Karen L. Jeske
Mrs. Susan Kelly
Lake Mohawk Golf Club
Mr. and Mrs. Ronald R. Lewis
Mack and Jacqueline Smith Charitable Fund
Mr. Scott A. Maddox
Ms. Tracey A. Majors
Ms. Cynthia S. McCrae
Mercy Service League
Ms. Elaine A. Miller
Motter & Meadows Architects
Mr. and Mrs. Michael Mulheim
Mr. and Mrs. Larry Parks
Mr. and Mrs. Herbert Pfeiffer
Progressive Chevrolet Company
Ms. Lois Rolli
Mrs. Leslie J. Russell
Ms. Carolyn Scheetz
Mrs. Connie Schmucker
Mr. and Mrs. Roger Schuckert
Ms. Kathleen Sickles
Mr. and Mrs. Mack D. Smith, Jr.
Ms. Yolanda Sparks
Stark County Sheriff’s Office
Temple Israel Sisterhood
Mr. and Mrs. David C. Thomson
Edward J. Walsh, M.D.
Ms. Kay Watson
Mrs. Nancy E. Yackey
Mr. and Mrs. Daniel G. Zimmerman
2018 to Mid-2019
Mercy Cancer Center extends heartfelt thanks to all the donors who help us provide the resources that assist cancer
patients and their families. Thank you for your sharing in our mission!
DONORS AND GIFTS
Not only are we with you through every step of the journey, but many patients, community members, volunteers, and staff give back to our cancer community through fundraisers and awareness events.
28
Wine, Women & ShoesMercy Service League hosted Wine, Women & shoes on May 18, 2019 at the Alex D. Krassas Event Center in Canton. The event was an upscale afternoon of shopping, wine tasting, silent and live auction, and a high-energy fashion show. Signet, an Akron-based private investment firm, was the presenting sponsor and Dina Rooney, M.D. served as Chairwoman of the Cause along with numerous other generous sponsors. Proceeds directly benefit women’s cancer services at Mercy Cancer Center.
Cancer Support Bags for PatientsEvery day, cancer patients face numerous challenges, from a ride to an appointment, to sore mouths, nausea, sitting in a treatment chair for hours, or just dealing with the feelings that accompany a diagnosis. Those who give cancer support bags put great thought into including items for comfort and support, small gifts that make a treatment day easier, or just remind the recipient that others are thinking of them in this most challenging time. Thank you to all those who put in the time, effort and expense to assemble these care packages!
Chemo Care Bags were donated by: • Jamey Petit of Simply Give
• Judy Stahl with Clever Containers
• Louisville High School National Honor Society
• St. Michael’s School
• S.P.A.R.K. Women’s Bible Study Group
Wine, Women & Shoes
29
Think Pink! Women’s Golf ScrambleThe Think Pink! Women’s Golf Scramble, held on June 26, 2018 and sponsored by the Lake Mohawk Golf Club, was held to raise money to benefit breast cancer patients and increase awareness. The funds they raised will go to support women with breast cancer and their ongoing needs. We are immensely grateful to receive their generous support!
The 10th Annual Cruisin for CancerThe 10th Annual Cruisin for Cancer was held on July 27, 2019. Rhonda and Perry Griffin organize this annual event that raises money to pay it forward for other cancer patients. The Griffins and friends have continued to make an enormous impact in our community through their benevolent work. We are grateful to Rhonda, Perry, their family and friends, and the Stark County Sheriff’s Office for their tremendous, ongoing support!
Think Pink! Women’s Golf Scramble
Cruisin for Cancer
30
Life is in the journey … let’s continue to step forward, together.
LOOKING AHEAD
30
3131
Keep walking with us, because exciting things are on the horizon, both in cancer care, and at Mercy Cancer Center.
We will continue to bring quality cancer care to our community in the coming year. As we do so, we will be exploring
research, giving state-of-the-art care, and supporting patients through treatment and into survivorship. We hope to have
a greater presence both in the community and online, making ourselves available to you throughout the cancer journey.
Let’s walk together!
Get Connected. Always be up-to-date on Mercy Medical Center happenings via social media.
Walk on, walk onWith hope in your heartAnd you’ll never walk alone
32
Approximately 15% of non-small cell lung cancers are diagnosed at an early stage (before the cancer has reached the lymph nodes in the center of the chest). Surgical resection remains the standard of care for these patients, resulting in 5 year survival rates of 60-70%. However, intrathoracic surgery carries significant risks, even for small peripheral lung tumors removed with robotic assistance, and many patients diagnosed with early stage non-small cell lung cancers have pre-existing lung and cardiac conditions, which make the risks of surgical resection of a lung tumor unacceptably high. These inoperable patients have traditionally been treated with 6-7 weeks of
conventionally fractionated radiotherapy with significantly inferior outcomes of 5 year survival rates approaching 20-30%.
In order to improve these outcomes, various novel radiation techniques were investigated to achieve the combination of increased tumor cell kill while simultaneously causing the same or fewer adverse effects.
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is a method of delivery of radiotherapy where higher radiation doses per treatment are given to small anatomic areas for a
Stereotactic Body Radiotherapy in Early Stage Non-Small Cell Lung Cancer
fewer overall number of treatments. The higher dose per treatment provides increased tumor cell kill despite the fewer number of total treatments, and targeting a small anatomic area reduces the risk of adverse effects.
In appropriately selected patients SBRT can provide a 2 year local control probability of 90-95%, a 5 year local control probability of 85-90%, and a 5 year probability of freedom from distant recurrence of 70-80%. Key characteristics of the patients in this group include those with a tumor size of less than 5cm, a peripheral tumor location (defined as >2cm from the proximal bronchial tree), and a lack of
Sarah Grabowski, M.D. Radiation Oncologist
Dr. Grabowski is a board certified radiation oncologist with Mercy Cancer Center. She is a graduate of Robert Wood Johnson Medical School, subsequently completing the Doris Duke Clinical Research Fellowship at University of North Carolina at Chapel Hill, and radiation oncology residency at University of Maryland Medical Center. She is a member of the Cancer Committee, participates in multidisciplinary site specific tumor conferences and steering committees, providing valuable input into the care of patients at Mercy Cancer Center.
SPOTLIGHT ON LUNG CANCER: Oncology Perspective
33
nodal involvement. Notably absent from these criteria is the requirement for a certain level of pulmonary reserve. Likely owing to the small volume of normal lung treated with the SBRT technique, it has been shown to be just as safe in patients with poor pulmonary reserve as in those with more optimal lung functioning.
More recently, the relative safety and efficacy of using SBRT for more centrally located tumors has been shown in several national and international phase II studies,
although caution is still advised when treating these lesions as the anatomic definition of a ‘central tumor’ and the dose fractionation used in these trials were variable. Similarly, several single institution studies and one multi-institutional study have also recently shown the relative safety of the SBRT technique in node negative patients with tumors larger than 5cm. However, while in these patients local control was still 73% at 2 years, distant failure occurred more frequently and at an earlier time point than in patients treated when their tumors were smaller.
In conclusion, the SBRT/SABR technique is an effective and safe treatment option for patients with early stage non-small cell lung cancer who are unable to undergo definitive surgical resection. Future directions for this technique currently under investigation include its use in patients with operable lung cancers and direct comparisons with more conventionally fractionated radiotherapy regimens.
PER
CEN
T (%
)
1
18
36
53
70
GENDER
PER
CEN
T (%
)
1
13
26
38
50
AGE GROUP
under 20 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90 and over
MALE FEMALE
MERCY
OTHER61%
51%
39%
49%
Source: National Cancer Database, 2016 (most recent data available)
Non-Small Cell Lung Cancer- Gender Distribution (Mercy vs. NCDB National, 2016)
PER
CEN
T (%
)
1
18
36
53
70
GENDER
PER
CEN
T (%
)
1
13
26
38
50
AGE GROUP
under 20 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90 and over
MERCY
OTHER
Non-Small Cell Lung Cancer: Stage at Diagnosis (Mercy vs NCDB National, 2016)
Non-Small Cell Lung Cancer: Age at Diagnosis (Mercy vs NCDB National, 2016)
2% 2%
15% 14%
42%
31% 31%34%
8%
16%
2% 1%0% 0%0% 0%0% 0%
33
34
The diagnosis of indeterminate mediastinal lymph nodes, peri bronchial and central lung masses constitutes a significant challenge in terms of tissue sampling. Options for tissue diagnoses include computed tomography–guided percutaneous biopsy, transbronchial fine-needle aspiration, mediastinoscopy, or video-assisted thoracoscopic surgery; however, these approaches have both advantages and limitations in terms of tissue yield, safety profile and cost. Endobronchial ultrasound (EBUS) is a relatively new minimally invasive technique that expands the view of the pulmonologist, beyond the lumen of the airway. There are two EBUS systems currently available. The radial probe
EBUS allows for evaluation of central airways accurate definition of airway invasion, and facilitates the diagnosis of peripheral lung lesions. Linear EBUS guides transbronchial needle aspiration of hilar and mediastinal lymph nodes, central mediastinal and paratracheal lesions, improving diagnostic and assisting with staging. Since Mercy Medical Center currently has the technology and expertise for Linear EBUS, this article will focus and highlight the role of this technology.
The reliability of Computed Tomography (CT) in predicting metastatic involvement of mediastinal lymph nodes and airway infiltration is limited.
For this reason, treatment decisions regarding chemotherapy and/or radiation therapy, or surgical resection require tissue confirmation in most patients. Even in the face of a known malignancy, mediastinal lymph nodes can be enlarged for reasons other than cancer (e.g., infection, sarcoidosis). Endobronchial biopsy under direct visualization can provide a diagnosis in more than 90% of cases. However, the majority of lung cancers present with primary lesions outside the direct view of the bronchoscope, and the yield of transbronchial needle aspiration for sampling the mediastinum varies widely. The view from a bronchoscope is limited to the lumen and the
Role of EBUS Bronchoscopy in Lung Cancer Diagnosis & Staging
M. Salman Khan, D.O., FCCP Pulmonologist
Dr. Khan is a pulmonologist at Mercy Medical Center who is board certified in Critical care, pulmonary and internal medicine.
He is the Medical Director of Respiratory Care at Mercy Medical Center, as well as serving on the Multidisciplinary Lung Conference team and Lung Program Steering Committee. He also serves on the Trauma Peer Review Committee and Ethics Committee.
SPOTLIGHT ON LUNG CANCER: Pulmonary Perspective
3535
internal surface of the airways; thus, expanding the pulmonologist’s view with ultrasound guidance, beyond the airways, could vastly improve the diagnostic capabilities of diagnostic bronchoscopy.
Endobronchial ultrasound–transbronchial needle aspiration (EBUS-TBNA) can be performed under local anesthesia and conscious sedation in an outpatient, as well as inpatient setting. Usually this procedure is performed in the operating room. Subsequent to the ultrasound guided biopsy, the aspirated material is smeared onto glass slides, air-dried and fixed in 95% alcohol. Dried smears can be evaluated by an on-site pathologist to confirm an adequate lymph node sampling. In a substantial number of cases a preliminary diagnosis can be made termed as Rapid on Site Evaluation (ROSE). The safety
EBU
S P
RO
CED
UR
ES
1
11
21
30
40
EBUS Trend
Q1 Q2 Q3 Q4
2017
2018
2019
36
of this technique is well established and few serious complications have been reported, including pneumothorax, pneumomediastinum and hemomediastinum. Furthermore, the risk of bleeding with fine needle puncture of the pulmonary artery is quite low. With that said, Mediastinoscopy is still considered the “gold standard” for the evaluation of mediastinal lymph nodes, but as a surgical procedure, it is costly, requires general anesthesia, and has an associated morbidity and mortality, albeit very low. In addition, standard cervical mediastinoscopy is ideally suited to the biopsy of lymph nodes within the upper mediastinum and
upper paratracheal locations; whereas posterior subcarinal, pulmonary ligament and subaortic nodes are usually inaccessible.
For non–small cell lung cancer (NSCLC) staging, when there is no evidence of distant metastases, EBUS guided bronchoscopy is the procedure of choice for evaluation of mediastinal lymph node involvement. Accurate staging of NSCLC is important not only to determine the patient’s prognosis, but to aid in deciding on a treatment plan, as the presence of mediastinal lymph node involvement is diagnostic for stage III lung cancer and suggests inoperability and the need for treatment
with chemotherapy, radiation or both. If the patient does not have nodal involvement, surgery is the treatment of choice.
EBUS guided bronchoscopy is minimally invasive, safe and highly accurate. It offers the advantage of simultaneously obtaining the diagnosis and stage of lung cancer in a single procedure in the outpatient setting, especially in patients who present with a lung mass, mediastinal adenopathy and no evidence of distant metastatic disease. Accurate diagnosis and staging of lung cancer in a timely manner is crucial for prognostic and therapeutic decision making.
PER
CEN
T (%
)
1
11
21
30
40
STAGE
0 I II III IV OC NA UNK
PER
CEN
T (%
)
1
8
16
23
30
FIRST COURSE TREATMENT
No
Firs
t C
ours
e R
x
Rad
iatio
n &
Che
emot
hera
py
Sur
gery
Onl
y
Rad
iatio
n O
nly
Che
mot
hera
py O
nly
Sur
gery
& C
hem
othe
rapy
Che
mot
hera
py &
BR
M
Sur
gery
, Rad
iatio
n &
Che
mot
hera
py
Oth
er S
peci
fied
Ther
apy
Sur
gery
& R
adia
tion
MERCY
OTHER
Non-Small Cell Lung Cancer: Stage at Diagnosis (Mercy vs NCDB National, 2016)
0% 0%
27%30%
14%
9%
21%18%
36%
40%
0% 0% 0% 0%3% 3%
PER
CEN
T (%
)
1
11
21
30
40
STAGE
0 I II III IV OC NA UNK
PER
CEN
T (%
)
1
8
16
23
30
FIRST COURSE TREATMENT
No
Firs
t C
ours
e R
x
Rad
iatio
n &
Che
emot
hera
py
Sur
gery
Onl
y
Rad
iatio
n O
nly
Che
mot
hera
py O
nly
Sur
gery
& C
hem
othe
rapy
Che
mot
hera
py &
BR
M
Sur
gery
, Rad
iatio
n &
Che
mot
hera
py
Oth
er S
peci
fied
Ther
apy
Sur
gery
& R
adia
tion
MERCY
OTHER
Non-Small Cell Lung Cancer: First Course Treatment (Mercy vs NCDB National, 2016)
13%
17%
10% 10%
5% 5%
2% 2%
18%19%
22%
19%
25%
19%
3% 2% 2%
5%
0% 1%
No
Firs
t C
ours
e R
x
Rad
iatio
n &
C
hem
othe
rapy
Sur
gery
Onl
y
Rad
iatio
n O
nly
Che
mot
hera
py
Onl
y
Sur
gery
&
Che
mot
hera
py
Che
mot
hera
py
& B
RM
Sur
gery
, R
adia
tion
&
Che
mot
hera
py
Oth
er
Spe
cifie
d Th
erap
y
Sur
gery
&
Rad
iatio
n
FIRST COURSE TREATMENT
37
37
Mercy Medical Center has continued support of the Cancer Registry since 1983 under the guidance of the Cancer Committee. The primary goal is to monitor all cancers diagnosed and/or treated at Mercy Medical Center and to provide quality data to administration, physicians and staff members.
We have continued our affiliation with ELEKTA, which enables the registry to collect, distribute and monitor accurate data, identify trends in incidence, distribution, treatment and end results by using METRIQ oncology data management system. The Cancer Registry submits all eligible cases to the Ohio Cancer Incidence Surveillance System (OCISS) through the Ohio Department of Health.
During 2018, the Cancer Registry completed 783 analytic cases and 54 non-analytic cases. Case mix identified 432 female patients (55.2%) and 351 male patients (44.8%), with 92% being Caucasian and 8% African American.
The Cancer Registry works closely with all aspects of cancer services to offer weekly Tumor Boards and Specialty Cancer Conferences specific to breast, lung and colorectal cancer. During 2018, we successfully presented 273 prospective cases through the above conferences with support of Administration, Department of Radiology, Department of Pathology and involvement of all physician specialties.
Mercy Cancer Registry continues to comply with the standards of the American College of Surgeons Guidelines for Approved Cancer Programs and is honored with the attainment of our fourth consecutive Outstanding Achievement Award received in 2017.
Respectfully submitted,
Carol A. Mulheim, CTR
2018 CANCER REGISTRY REPORT
Carol A. Mulheim, CTR
37
38
RESOURCES FOR PATIENTS, FAMILIES AND PHYSICIANS
Administrative Director, Cancer Services 330-458-4230
Blood Donor Room 330-489-1076
Breast Care Center 330-580-4727 Nurse Navigator 330-489-1493 Appointments/Mammography Scheduling
Cancer Information Line 330-430-2788 1-888-293-4673 (toll free)
Cancer Navigators 330-430-2777 (All Cancers) 330-588-4674 (All Cancers) 330-588-4686 (All Cancers) 330-588-4588 (Colorectal Cancer) 330-580-4727 (Breast Cancer)
330-458-4214 (Lung Cancer)
Cancer Registry 330-489-1000 ext. 1861
Cancer Research Coordinators 330-489-1274 330-588-4589 330-489-8118
Cancer Support Groups and Complementary Medicine Program 330-430-2788
Cancer Well Fit 330-966-8997
Homecare 234-203-3211
Hospice 234-203-3223
Inpatient Oncology Unit 330-489-1244
Lung Center 330-458-4214
Mercy Boutique 330-456-9960
Nutritional Services 330-489-1199
Occupational Therapy 330-489-1135
Outpatient Infusion Center 330-489-1375
Palliative Care Service 234-203-3224
Pastoral Care 330-489-1143
Physical Therapy 330-489-1135
Physician Referral 330-489-1333 (local)
1-800-223-8662 (toll free)
Professional Pharmacy 330-489-1400
Radiation Oncology 330-489-1278
Seeds of Hope Grief & Loss 330-489-1143
Social Services 330-489-1377
Speech Therapy 330-489-1135
One-CallCancer Referral Line
1.888.293.4673 (toll-free) 330.458.4128 (local)
Let us expedite your care
Navigating the complexities of cancer care can be daunting for both patient and primary care physician. With One-Call, our cancer navigators can coordinate consultations, testing, treatment, report results and more.
In short, we facilitate and organize the process while keeping both patient and primary care physician in control and in the loop.
So your doctors can be free to focus on what is most important … you.
ASK YOUR PRIMARY CARE PHYSICIAN TO TAKE ADVANTAGE OF…
39
cantonmercy.org 1320 Mercy Drive NW, Canton, OH 44708 • 330-489-1000 • 1-800-999-8662
